Navidea Biopharmaceuticals Net Income 2010-2023 | NAVB

Navidea Biopharmaceuticals net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Navidea Biopharmaceuticals Net Income 2010-2023 | NAVB

Navidea Biopharmaceuticals net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185.9B
Thermo Fisher Scientific (TMO)$156.6B
Edwards Lifesciences (EW)$44.9B
Alcon (ALC)$43.1B
IDEXX Laboratories (IDXX)$41.4B
DexCom (DXCM)$32.9B
IQVIA Holdings (IQV)$27.8B
Mettler-Toledo (MTD)$24.8B
STERIS (STE)$22.2B
SONOVA HOLDING (SONVY)$17.4B
Waters (WAT)$17.1B
Hologic (HOLX)$14.3B
Sysmex ADR (SSMXY)$10.4B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.4B
Globus Medical (GMED)$7.6B
Glaukos (GKOS)$5.6B
Teleflex (TFX)$4.9B
Integer Holdings (ITGR)$3.9B
TransMedics (TMDX)$3.7B
PROCEPT BioRobotics (PRCT)$3.2B
LivaNova (LIVN)$2.3B
Elekta AB (EKTAY)$1.9B
Nihon Kohden (NHNKY)$1.9B
Veracyte (VCYT)$1.8B
Alphatec Holdings (ATEC)$1.5B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B